Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
901 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01998906 | A Study of Herceptin (Trastuzumab) in Combination Chemotherapy in Women With Locally Advanced Breast Cancer | completed | Phase 3 | 330 | Hoffmann-La RocheINDUSTRY | 6 | Oct 28, 2014 | clinicaltrials |
| NCT00448279 | THOR Study: A Study of Continued Herceptin (Trastuzumab) in Combination With Second Line Chemotherapy in Patients With HER2 Positive Metastatic Breast Cancer. | completed | Phase 3 | 58 | Hoffmann-La RocheINDUSTRY | 1 | Oct 24, 2014 | clinicaltrials |
| NCT00520403 | A Study of Avastin (Bevacizumab) in Combination With Standard Therapy in Patients With Metastatic Renal Cell Cancer. | completed | Phase 2 | 25 | Hoffmann-La RocheINDUSTRY | 1 | Oct 13, 2014 | clinicaltrials |
| NCT01196052 | A Study of Trastuzumab Emtansine (T-DM1) Sequentially With Anthracycline-based Chemotherapy, as Adjuvant or Neoadjuvant Therapy for Patients With Early Stage Herceptin (HER)2-positive Breast Cancer | completed | Phase 2 | 153 | Hoffmann-La RocheINDUSTRY | 8 | Oct 6, 2014 | clinicaltrials |
| NCT00720798 | An Extension Study of Tocilizumab (Myeloma Receptor Antibody [MRA]) in Patients Completing Treatment in Tocilizumab Core Studies | completed | Phase 3 | 2,067 | Hoffmann-La RocheINDUSTRY | 34 | Sep 30, 2014 | clinicaltrials |
| NCT01928615 | A Study of Subcutaneously Administered Herceptin (Trastuzumab) in Patients With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Early Breast Cancer(LISAH) | terminated | Phase 2 | 2 | Hoffmann-La RocheINDUSTRY | 1 | Sep 29, 2014 | clinicaltrials |
| NCT00700180 | A Study of Avastin (Bevacizumab) in Combination With Carboplatin-Based Chemotherapy in Patients With Advanced or Recurrent Non-Squamous Non-Small Cell Lung Cancer. | completed | Phase 2 | 303 | Hoffmann-La RocheINDUSTRY | 16 | Sep 25, 2014 | clinicaltrials |
| NCT02013765 | A Study of Herceptin (Trastuzumab) Monotherapy in Patients With Metastatic Urothelial Cancer | terminated | Phase 2 | 5 | Hoffmann-La RocheINDUSTRY | 1 | Sep 25, 2014 | clinicaltrials |
| NCT00475670 | A Study of Herceptin (Trastuzumab) in Women With Metastatic Breast Cancer | completed | Phase 2 | 44 | Hoffmann-La RocheINDUSTRY | 15 | Sep 15, 2014 | clinicaltrials |
| NCT01609010 | A Study of MabThera/Rituxan (Rituximab) Alone and in Combination With Roferon-A in Patients With Follicular or Other CD20+ Low-Grade (Indolent) Lymphoma | completed | Phase 3 | 313 | Hoffmann-La RocheINDUSTRY | 3 | Sep 8, 2014 | clinicaltrials |
| NCT00576199 | A Study of Avastin (Bevacizumab) and Transarterial Chemoembolisation (TACE) Treatment in Patients With Liver Cancer | completed | Phase 2 | 30 | Hoffmann-La RocheINDUSTRY | 1 | Aug 29, 2014 | clinicaltrials |
| NCT00576758 | GAUSS: A Study of Obinutuzumab (RO5072759) in Patients With Indolent Non-Hodgkin's Lymphoma | completed | Phase 2 | 175 | Hoffmann-La RocheINDUSTRY | 17 | Aug 19, 2014 | clinicaltrials |
| NCT01159171 | A Study of Avastin (Bevacizumab) and Oxaliplatin Plus Xeloda (Capecitabine) in Patients With Advanced Colorectal Cancer. | completed | Phase 2 | 50 | Hoffmann-La RocheINDUSTRY | 1 | Aug 15, 2014 | clinicaltrials |
| NCT01214720 | A Study of Avastin (Bevacizumab) Added to a Chemotherapeutic Regimen in Patients With Metastatic Pancreatic Cancer | completed | Phase 3 | 607 | Hoffmann-La RocheINDUSTRY | 21 | Aug 13, 2014 | clinicaltrials |
| NCT00576901 | A Study of Avastin (Bevacizumab) in Combination With Xeloda (Capecitabine) and Docetaxel in Patients With Inflammatory or Locally Advanced Breast Cancer. | terminated | Phase 2 | 23 | Hoffmann-La RocheINDUSTRY | 1 | Aug 11, 2014 | clinicaltrials |
| NCT01363986 | A Study of Herceptin (Trastuzumab) in Combination With Whole Brain Radiotherapy in Patients With HER-2 Positive Breast Cancer | terminated | Phase 2 | 3 | Hoffmann-La RocheINDUSTRY | 1 | Aug 11, 2014 | clinicaltrials |
| NCT02005484 | A Study of Herceptin (Trastuzumab) in Patients With Metastatic or Advanced Gastric Cancer With Disease Progression | terminated | Phase 2 | 6 | Hoffmann-La RocheINDUSTRY | 2 | Aug 11, 2014 | clinicaltrials |
| NCT00517699 | A Study of MabThera (Rituximab) in Primary Central Nervous System Lymphoma. | terminated | Phase 2 | 5 | Hoffmann-La RocheINDUSTRY | 1 | Aug 8, 2014 | clinicaltrials |
| NCT00623805 | A Study of Avastin (Bevacizumab) and Xeloda (Capecitabine) as Maintenance Treatment in Patients With Metastatic Colorectal Cancer | completed | Phase 3 | 123 | Hoffmann-La RocheINDUSTRY | 1 | Aug 8, 2014 | clinicaltrials |
| NCT01181609 | A Study of Avastin (Bevacizumab) Combined With Chemotherapy in Patients With Metastatic Cancer of the Colon or Rectum | completed | Phase 2 | 54 | Hoffmann-La RocheINDUSTRY | 1 | Jul 28, 2014 | clinicaltrials |
| NCT00846027 | A Study of Avastin (Bevacizumab) in Combination With Taxane-based Chemotherapy as First Line Treatment in Patients With HER-2 Negative Breast Cancer | completed | Phase 2 | 90 | Hoffmann-La RocheINDUSTRY | 1 | Jul 23, 2014 | clinicaltrials |
| NCT00605722 | A Study of Tarceva (Erlotinib) and Avastin (Bevacizumab) in Patients With Advanced or Metastatic Liver Cancer. | completed | Phase 2 | 51 | Hoffmann-La RocheINDUSTRY | 3 | Jul 14, 2014 | clinicaltrials |
| NCT02005549 | A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Primary Breast Cancer | completed | Phase 2 | 18 | Hoffmann-La RocheINDUSTRY | 1 | Jul 14, 2014 | clinicaltrials |
| NCT00661778 | A Study of Avastin (Bevacizumab) in Combination With Docetaxel and Cisplatin in Patients With Metastatic or Locally Advanced Non-small Cell Lung Cancer | completed | Phase 2 | 50 | Hoffmann-La RocheINDUSTRY | 1 | Jul 10, 2014 | clinicaltrials |
| NCT01996332 | A Study of Tarceva (Erlotinib) Monotherapy in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 2 | 1,805 | Hoffmann-La RocheINDUSTRY | 1 | Jul 10, 2014 | clinicaltrials |
| NCT02079519 | A Study of Avastin (Bevacizumab) in Patients With Multiple Myeloma | terminated | Phase 2 | 10 | Hoffmann-La RocheINDUSTRY | 1 | Jul 8, 2014 | clinicaltrials |
| NCT00754650 | A Proof of Concept Study of the Safety, Tolerability, and Efficacy of Avastin (Bevacizumab) in Patients With Chemo-naive Chronic Lymphocytic Leukemia | completed | Phase 2 | 2 | Hoffmann-La RocheINDUSTRY | 1 | Jun 26, 2014 | clinicaltrials |
| NCT02013830 | A Study of Avastin (Bevacizumab) and Xeloda (Capecitabine) in Patients With Advanced or Metastatic Liver Cancer | completed | Phase 2 | 45 | Hoffmann-La RocheINDUSTRY | 4 | Jun 6, 2014 | clinicaltrials |
| NCT02151370 | An Observational Study of Avastin (Bevacizumab) in Patients With Ovarian Cancer | completed | — | 3 | Hoffmann-La RocheINDUSTRY | 1 | May 30, 2014 | clinicaltrials |
| NCT01118377 | A Study of Capecitabine (Xeloda®) and Concomitant Radiation Therapy in Children With Newly Diagnosed Brainstem Gliomas | completed | Phase 2 | 45 | Hoffmann-La RocheINDUSTRY | 1 | Feb 6, 2014 | clinicaltrials |
| NCT00502736 | A Study of Loading Doses of Intravenous Bondronat (Ibandronate) in Patients With Breast Cancer and Malignant Bone Disease. | completed | Phase 2 | 13 | Hoffmann-La RocheINDUSTRY | 1 | Jan 22, 2014 | clinicaltrials |
| NCT00711191 | A Study On An Immunostimulant Antibody In Combination With Chemotherapy For Advanced Cancer Of The Pancreas | completed | Phase 1 | 22 | Hoffmann-La RocheINDUSTRY | 1 | Dec 24, 2013 | clinicaltrials |
| NCT00721123 | A Long-term Extension Study of Tocilizumab (Myeloma Receptor Antibody [MRA]) in Patients With Rheumatoid Arthritis | completed | Phase 3 | 538 | Hoffmann-La RocheINDUSTRY | 17 | Nov 28, 2013 | clinicaltrials |
| NCT01991340 | H.E.R.O.S. Study: An Observational Study of the Cardiac Safety of Herceptin (Trastuzumab) in Patients With HER2-Positive Breast Cancer | completed | — | 657 | Hoffmann-La RocheINDUSTRY | 2 | Nov 25, 2013 | clinicaltrials |
| NCT00281918 | Fludarabine and Cyclophosphamide With or Without Rituximab in Patients With Previously Untreated Chronic B-Cell Lymphocytic Leukemia(CLL-8) | completed | Phase 3 | 817 | Hoffmann-La RocheINDUSTRY | 11 | Sep 19, 2013 | clinicaltrials |
| NCT00112918 | Combination Chemotherapy With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for High Risk Stage II or Stage III Colon Cancer | completed | Phase 3 | 3,451 | Hoffmann-La RocheINDUSTRY | 1 | Aug 27, 2013 | clinicaltrials |
| NCT00773383 | A Study of the Effect of R1507 in Combination With Tarceva (Erlotinib) on Progression-Free Survival in Patients With Stage IIIb/IV Non-Small Cell Lung Cancer (NSCLC) Having Received Tarceva Monotherapy. | terminated | Phase 2 | 35 | Hoffmann-La RocheINDUSTRY | 4 | Jun 24, 2013 | clinicaltrials |
| NCT00077857 | A Study to Assess Capecitabine (Xeloda®) in Patients With Locally Advanced or Metastatic Breast Cancer | completed | Phase 2 | 470 | Hoffmann-La RocheINDUSTRY | 9 | May 10, 2013 | clinicaltrials |
| NCT01209689 | A Study of Tocilizumab (RoActemra/Actemra) in Patients With Ankylosing Spondylitis Who Have Had an Inadequate Response to Previous Tumor Necrosis Factor (TNF) Antagonist Therapy | terminated | Phase 3 | 113 | Hoffmann-La RocheINDUSTRY | 19 | Jan 17, 2013 | clinicaltrials |
| NCT00089479 | A Study of Xeloda (Capecitabine) in Women With High-Risk Breast Cancer | completed | Phase 3 | 2,611 | Hoffmann-La RocheINDUSTRY | 1 | Dec 21, 2012 | clinicaltrials |
| NCT00349336 | A Study of Avastin (Bevacizumab) in Combination With XELOX or FOLFOX-4 in Patients With Metastatic Colorectal Cancer. | completed | Phase 3 | 64 | Hoffmann-La RocheINDUSTRY | 3 | Sep 18, 2012 | clinicaltrials |
| NCT00127933 | XeNA Study - A Study of Xeloda (Capecitabine) in Patients With Invasive Breast Cancer | completed | Phase 4 | 157 | Hoffmann-La RocheINDUSTRY | 1 | Aug 10, 2011 | clinicaltrials |
| NCT00121836 | A Study of Xeloda (Capecitabine) in Women With HER2-Negative Metastatic Breast Cancer | completed | Phase 4 | 109 | Hoffmann-La RocheINDUSTRY | 1 | Apr 27, 2011 | clinicaltrials |
| NCT00118755 | A Study of Two Different Schedules of Xeloda (Capecitabine) as First Line Therapy in Patients With Metastatic Colorectal Cancer | completed | Phase 2 | 435 | Hoffmann-La RocheINDUSTRY | 0 | Mar 3, 2011 | clinicaltrials |
| NCT00683969 | A Study to Assess the Effect of CellCept (Mycophenolate Mofetil) and Reduced Corticosteroids in Controlling Symptoms of Myasthenia Gravis | completed | Phase 3 | 136 | Hoffmann-La RocheINDUSTRY | 14 | May 26, 2008 | clinicaltrials |
Data updated 23 days agoSource updated unknownsource: clinicaltrials